Strong Medicine
Peter Day visits two Swiss pharmaceutical companies, one huge and one tiny and linked by their quest for a treatment for Alzheimer's, to look at the future of drug discovery.
Big problems loom over the pharmaceutical industry which influences so many people's lives. Giant corporations are beset by scandal and their pipelines of new treatments are running dry. Peter Day looks at the future of the industry through the eyes of two Swiss pharma companies, one very big and one of them tiny. Both are linked by their quest for a treatment for Alzheimers.
Producer: Sandra Kanthal.
Last on
More episodes
Previous
Contributors to this programme
Severin Schwan
CEO, Roche
Ìý
Andreas Knierzinger
Head Treasury and Financing, Roche
Ìý
Michael Owen
Chairman, Sami Consulting
Ìý
Luca Santerelli
Head of Neuroscience, Roche
Ìý
Andrea Pfeifer
CEO, AC Immune
Ìý
Broadcasts
- Thu 6 Dec 2012 20:30ÃÛÑ¿´«Ã½ Radio 4
- Sun 9 Dec 2012 21:30ÃÛÑ¿´«Ã½ Radio 4
Download this programme
Subscribe to this programme or download individual episodes.